Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-09-16
1998-09-22
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31225
Patent
active
058114572
ABSTRACT:
A therapeutical method for treating chronic arteriosclerosis obliterans in particularly selected patients with severely disabling intermittent claudication is disclosed, which comprises administering propionyl L-carnitine or a pharmacologically acceptable salts thereof.
REFERENCES:
patent: 4343816 (1982-08-01), Cavazza
patent: 4968719 (1990-11-01), Brevetti
Dialog On-line Print of Sigma-Tau Research and Development (R&D) update, 1991.
Henley III Raymond
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Therapeutical method for treating chronic arteriosclerosis oblit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutical method for treating chronic arteriosclerosis oblit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutical method for treating chronic arteriosclerosis oblit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1622175